Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,758.82
(
-0.16%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
104.37
(
-2.08%
)
Bitcoin
70,390.45
(
-1.19%
)
News Focus
News Focus

Replies to post #172667 on Biotech Values

Replies to #172667 on Biotech Values
icon url

north40000

01/14/14 2:15 PM

#172680 RE: DewDiligence #172667

It already has competition, off-label, from Vascepa[AMRN]. Anecdotal, of course, but works for me and others taking the 96% EPA content Vascepa capsules, 4/day.
No results from Restasis on this front.
icon url

DewDiligence

01/14/14 2:22 PM

#172681 RE: DewDiligence #172667

AGN wins US patent lawsuit re generic Lumigan:

http://www.sec.gov/Archives/edgar/data/850693/000119312514010528/d657838d8k.htm
icon url

DewDiligence

01/22/14 10:04 AM

#173050 RE: DewDiligence #172667

ACT files P-IV challenge for AGN’s Restasis:

http://www.sec.gov/Archives/edgar/data/850693/000119312514016743/d660120d8k.htm